Duets for Type 2 Diabetes™

Managing type 2 diabetes doesn't have to be a solo act. ||| h5

In the U.S., about half of people living with type 2 diabetes struggle to reach an A1C of less than 7%. Support–from family, friends or a treatment plan in partnership with a healthcare provider– can help make a difference in type 2 diabetes management care.


That’s why Lilly launched Duets for Type 2 Diabetes™, a campaign that celebrates the partnerships that help people navigate life with type 2 diabetes.

https://main--ewi-mounjaro-aem-us--elilillyco.aem.page/fragments/figure-captions/duets-landing-page-video

Eric Stonestreet and his mom, Jamey, have type 2 diabetes, take Mounjaro and are paid Lilly spokespeople.

Eric & Jamey’s Journey: Finding Strength in Support ||| mounjaro-purple

Actor Eric Stonestreet and his mother, Jamey Stonestreet, are sharing their personal type 2 diabetes experiences to elevate stories of support. ||| mounjaro-purple


https://main--ewi-mounjaro-aem-us--elilillyco.aem.page/fragments/quotes/eric-stonestreet

*Individual results and experiences on Mounjaro may vary. ||| mt-3

In studies with or without other diabetes medications, 75% to 90% of people taking Mounjaro reached an A1C of less than 7%, with an average starting A1C of 7.9% to 8.6% across the 5-mg, 10-mg, and 15-mg doses.

Mounjaro is not a weight loss drug. In studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5 mg) to 25 lb (15 mg).

https://main--ewi-mounjaro-aem-us--elilillyco.aem.page/fragments/figure-captions/duets-immersion-day-video

Duets for Type 2 Diabetes™ is a trademark owned or licensed by Eli Lilly and Company. Other product/company names mentioned herein are the trademarks of their respective owners.